Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 24401-24450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05614024
Neurofeedback During Eating for Bulimia Nervosa
NARecruiting
30 participants
Started: May 13, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06418282
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
NARecruiting
50 participants
Started: May 13, 2024 · Completed: Jan 31, 2025
3 conditions1 sponsor1 location
NCT06372964
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
PHASE3Recruiting
384 participants
Started: May 13, 2024 · Completed: May 31, 2027
1 condition1 sponsor59 locations
NCT06322056
Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease
NARecruiting
642 participants
Started: May 13, 2024 · Completed: Aug 31, 2029
3 conditions1 sponsor1 location
NCT06269146
Pramipexole to Enhance Social Connections
PHASE2Recruiting
108 participants
Started: May 13, 2024 · Completed: Mar 31, 2026
4 conditions3 sponsors2 locations
NCT06511154
The Effect of Cognitive Exercise on Upper Extremity Functions, Balance and Cognitive Functions in Multiple Sclerosis
NARecruiting
32 participants
Started: May 13, 2024 · Completed: Jun 15, 2025
1 condition2 sponsors1 location
NCT06487364
Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8
N/ARecruiting
39 participants
Started: May 13, 2024 · Completed: Sep 17, 2025
1 condition1 sponsor1 location
NCT06848647
Treatment of Sleep Apnea to Improve Metabolic Health
N/ARecruiting
600 participants
Started: May 13, 2024 · Completed: Dec 31, 2028
4 conditions2 sponsors1 location
NCT06127342
Exercise and Emotional Learning in Posttraumatic Stress Disorder
NARecruiting
100 participants
Started: May 13, 2024 · Completed: Nov 30, 2026
1 condition3 sponsors2 locations
NCT06718530
Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development
N/ARecruiting
1,000 participants
Started: May 13, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT06299215
Factors and Prognosis of Obstructive Pyelonephritis Patients
N/ARecruiting
1,000 participants
Started: May 13, 2024 · Completed: Mar 1, 2026
2 conditions1 sponsor1 location
NCT06362538
The Cardiovascular Prevention Program
NARecruiting
150 participants
Started: May 13, 2024 · Completed: Apr 15, 2027
1 condition1 sponsor1 location
NCT06383689
Placebo Optimization of the Presurgical Long-term Video-EEG Monitoring
NARecruiting
90 participants
Started: May 13, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04463576
Drug Interactions in Hospital Information System. The PRoSIT System..
N/ARecruiting
5,769 participants
Started: May 13, 2024 · Completed: Jul 31, 2025
1 condition2 sponsors3 locations
NCT06017817
Antibacterial Photodynamic Therapy in the Management of Peri-implantitis
NARecruiting
80 participants
Started: May 13, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06417554
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
80 participants
Started: May 13, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06453980
Multimodal Investigation of Neural Plasticity
NARecruiting
80 participants
Started: May 13, 2024 · Completed: Jan 31, 2026
1 condition3 sponsors1 location
NCT06037460
TocilizuMab discontinuAtion in GIant Cell Arteritis
PHASE3Recruiting
120 participants
Started: May 13, 2024 · Completed: Nov 30, 2028
1 condition1 sponsor1 location
NCT06202625
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
PHASE2/PHASE3Recruiting
142 participants
Started: May 13, 2024 · Completed: Oct 30, 2025
2 conditions10 sponsors14 locations
NCT06821919
Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
N/ARecruiting
70 participants
Started: May 13, 2024 · Completed: Dec 30, 2031
2 conditions1 sponsor1 location
NCT06484699
Open Versus Laparoscopic Repair of Perforated Peptic Ulcer
NARecruiting
50 participants
Started: May 13, 2024 · Completed: Jun 25, 2025
1 condition1 sponsor1 location
NCT06239350
Young Adult Tobacco/Nicotine and Cannabis Co-use
NARecruiting
350 participants
Started: May 13, 2024 · Completed: Jan 3, 2028
2 conditions2 sponsors1 location
NCT06506968
Ergonomics in the Cardiac Catheterization Laboratory
N/ARecruiting
30 participants
Started: May 13, 2024 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT06433349
A Multi-center Investigation of Family Health.
N/ARecruiting
240 participants
Started: May 13, 2024 · Completed: Dec 31, 2028
5 conditions4 sponsors1 location
NCT06309966
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
PHASE2/PHASE3Recruiting
390 participants
Started: May 13, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor152 locations
NCT06506201
Legs Dysmetria in Total Hip Replacement: Does Hip Approacches and Navigation Decrease the Risk?
NARecruiting
136 participants
Started: May 13, 2024 · Completed: May 12, 2027
1 condition1 sponsor1 location
NCT06490263
the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human
PHASE1Recruiting
68 participants
Started: May 13, 2024 · Completed: Dec 10, 2024
2 conditions2 sponsors1 location
NCT06208293
Suicide Prevention Integration Into Task-shifted Mental Health Interventions
NARecruiting
50 participants
Started: May 13, 2024 · Completed: Jan 31, 2026
3 conditions2 sponsors1 location
NCT06222034
Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
PHASE1Recruiting
10 participants
Started: May 13, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor9 locations
NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
PHASE1/PHASE2Recruiting
120 participants
Started: May 13, 2024 · Completed: Dec 31, 2026
13 conditions1 sponsor12 locations
NCT06398210
Investigation of the Effectiveness of Cognitive Exercise Therapy Approach in Patients With Primary Sjögren's Syndrome
NARecruiting
54 participants
Started: May 13, 2024 · Completed: Aug 30, 2025
1 condition1 sponsor1 location
NCT06721468
Trout Consumption in Young Children and Families and Brain Health
NARecruiting
99 participants
Started: May 13, 2024 · Completed: Dec 31, 2027
2 conditions2 sponsors2 locations
NCT06408194
Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
PHASE1Recruiting
20 participants
Started: May 13, 2024 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT06454383
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
PHASE1Recruiting
19 participants
Started: May 13, 2024 · Completed: Nov 13, 2026
4 conditions2 sponsors1 location
NCT06245941
A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
PHASE1/PHASE2Recruiting
93 participants
Started: May 13, 2024 · Completed: May 31, 2027
1 condition1 sponsor5 locations
NCT05577247
Belief Updating in Treatment Resistant Depression
N/ARecruiting
60 participants
Started: May 13, 2024 · Completed: Feb 15, 2025
1 condition1 sponsor1 location
NCT06266442
M. Avium WGS During Mav-PD Treatment
N/ARecruiting
40 participants
Started: May 13, 2024 · Completed: Sep 30, 2026
5 conditions3 sponsors1 location
NCT06398509
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
NARecruiting
576 participants
Started: May 13, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors2 locations
NCT06356428
Psychometric Properties and Cross-cultural Adaptation of the Turkish Version of Physcian Attitudes Toward Cardiac Rehabilitation and Referral Scale-Revised (PACRR-R)
N/ARecruiting
100 participants
Started: May 13, 2024 · Completed: Aug 13, 2025
1 condition1 sponsor1 location
NCT05551325
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
NARecruiting
160 participants
Started: May 13, 2024 · Completed: Jun 29, 2028
3 conditions2 sponsors2 locations
NCT06451679
Postoperative Dietary Intake of Hip Fracture Patients
N/ARecruiting
30 participants
Started: May 13, 2024 · Completed: Aug 31, 2024
4 conditions1 sponsor1 location
NCT06907589
A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care
NARecruiting
250 participants
Started: May 13, 2024 · Completed: Jan 8, 2026
2 conditions1 sponsor5 locations
NCT05864794
Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
NARecruiting
100 participants
Started: May 13, 2024 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT06241248
Evaluation of the Performance of a New Rapid Bacteremia Test in the Intensive Care Patient
N/ARecruiting
110 participants
Started: May 13, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06413615
A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors
PHASE2Recruiting
150 participants
Started: May 13, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06713681
Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery
N/ARecruiting
40 participants
Started: May 13, 2024 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06545136
Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)
PHASE1/PHASE2Recruiting
75 participants
Started: May 13, 2024 · Completed: May 31, 2029
1 condition1 sponsor4 locations
NCT06141993
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
N/ARecruiting
120 participants
Started: May 13, 2024 · Completed: Apr 30, 2027
4 conditions3 sponsors3 locations
NCT06190197
Prophylactic Antibiotics in Cystectomy With Diversion
EARLY_PHASE1Recruiting
120 participants
Started: May 13, 2024 · Completed: Oct 15, 2026
4 conditions1 sponsor1 location
NCT05950139
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
PHASE1/PHASE2Recruiting
12 participants
Started: May 13, 2024 · Completed: Jul 31, 2029
2 conditions2 sponsors1 location